Latest research published ahead of print in the New England Journal of Medicine details promising results from a trial of gene therapy for nephropathic cystinosis, a rare, life-threatening genetic disorder. The study focuses on a novel approach to deliver a functional copy of the CTNS gene, which is mutated in individuals with the disease, directly to kidney cells.
Nephropathic cystinosis causes a buildup of cystine within cells, leading to kidney damage, growth failure, and other complications. Current treatment involves medication to reduce cystine levels, but it does not address the underlying genetic defect and requires lifelong adherence. The new research explores the potential for a one-time gene therapy treatment to correct the genetic flaw and halt disease progression.
The New England Journal of Medicine, founded in 1812, is a highly respected peer-reviewed medical journal, currently ranking second out of 168 journals in the category of “Medicine, General & Internal” with an impact factor of 78.5 as of 2024. The journal is published weekly by the Massachusetts Medical Society.
Details of the trial, including patient demographics and long-term outcomes, are still forthcoming in the full publication. However, preliminary data suggest the gene therapy was well-tolerated and demonstrated a measurable impact on cystine accumulation in the kidneys of treated patients. Researchers are cautiously optimistic that this approach could offer a curative option for individuals with nephropathic cystinosis.
Alongside the gene therapy research, the current issue of the journal likewise features an editorial examining the use of CAR-T therapy for relapsed multiple myeloma. The editorial analyzes recent trial data and discusses the challenges of managing adverse events associated with this type of immunotherapy. The New England Journal of Medicine’s website currently highlights these two studies as key features of its latest content.
The Massachusetts Medical Society has published the New England Journal of Medicine since its inception, initially as the New England Journal of Medicine and Surgery and Collateral Branches of Science in January 1812. The journal’s evolution reflects the broader development of medical science and publishing over the past two centuries.
